{"organizations": [], "uuid": "63c3dff2a22cfcb1ee26cea4b1fa87d974ccb183", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180422.html", "section_title": "Archive News &amp; Video for Sunday, 22 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/britain-press-ft/press-digest-financial-times-april-23-idUSL3N1RZ0WH", "country": "US", "domain_rank": 408, "title": "PRESS DIGEST- Financial Times - April 23", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.405, "site_type": "news", "published": "2018-04-23T07:40:00.000+03:00", "replies_count": 0, "uuid": "63c3dff2a22cfcb1ee26cea4b1fa87d974ccb183"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/britain-press-ft/press-digest-financial-times-april-23-idUSL3N1RZ0WH", "ord_in_thread": 0, "title": "PRESS DIGEST- Financial Times - April 23", "locations": [], "entities": {"persons": [{"name": "bengaluru", "sentiment": "none"}], "locations": [{"name": "uk", "sentiment": "none"}, {"name": "britain", "sentiment": "none"}], "organizations": [{"name": "financial times", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "allied healthcare", "sentiment": "none"}, {"name": "macquarie", "sentiment": "none"}, {"name": "evelozcity on.ft.com/2hn8xlo - macquarie", "sentiment": "none"}, {"name": "calon energy", "sentiment": "none"}, {"name": "healthcare", "sentiment": "none"}, {"name": "opel karl-thomas neumann", "sentiment": "none"}, {"name": "supreme imports", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 23 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.\nHeadlines\n- Allied Healthcare lines up rescue plan on.ft.com/2qSphQb\n- Ex-Opel CEO joins electric vehicle start-up Evelozcity on.ft.com/2Hn8xLO\n- Macquarie considering sale of Calon Energy plants on.ft.com/2qSQDWf\n- Ecigarette maker Supreme Imports set for IPO on.ft.com/2HkNaLr\nOverview\n- Allied Healthcare will file for a company voluntary arrangement on Monday giving the company four weeks to agree a revised schedule of repayments with creditors.\n- Former chief executive of Opel Karl-Thomas Neumann has joined Los Angeles-based electric vehicle start-up Evelozcity.\n- Macquarie is considering putting its spinout Calon Energy’s three large UK gas-fired power plants up for sale.\n- Supreme Imports, one of Britain’s biggest makers of liquids for e-cigarettes, is seeking a stock market flotation and is expecting to be valued at 150 million pounds ($209.99 million).\n$1 = 0.7143 pounds Compiled by Bengaluru newsroom\n ", "external_links": ["https://on.ft.com/2Hn8xLO", "https://twitter.com/reuters", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://on.ft.com/2qSQDWf", "https://www.thomsonreuters.com/en/privacy-statement.html", "https://www.youtube.com/user/ReutersVideo", "https://on.ft.com/2HkNaLr", "https://instagram.com/reuters/", "https://on.ft.com/2qSphQb"], "published": "2018-04-23T07:40:00.000+03:00", "crawled": "2018-04-23T22:23:45.096+03:00", "highlightTitle": ""}